BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Cantor Fitzgerald
Federal Trade Commission
Farmers Insurance
Chinese Patent Office

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018200

« Back to Dashboard

NDA 018200 describes MIDAMOR, which is a drug marketed by Paddock Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the MIDAMOR profile page.

The generic ingredient in MIDAMOR is amiloride hydrochloride. There are five drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride profile page.
Summary for 018200
Applicant:Paddock Llc
Ingredient:amiloride hydrochloride
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 018200
Medical Subject Heading (MeSH) Categories for 018200
Suppliers and Packaging for NDA: 018200
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MIDAMOR amiloride hydrochloride TABLET;ORAL 018200 NDA KAISER FOUNDATION HOSPITALS 0179-0230 0179-0230-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0230-70)
MIDAMOR amiloride hydrochloride TABLET;ORAL 018200 NDA Paddock Laboratories, LLC 0574-0292 0574-0292-01 100 TABLET in 1 BOTTLE (0574-0292-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.